Clinical trial Recruiting at 1 site Interventional Ages 18 to 35 Women only

High-frequency rTMS to change food choices in anorexia nervosa

Official title: Deciphering the Neural Mechanisms of Restrictive Eating in Anorexia Nervosa Using Repetitive Transcranial Magnetic Stimulation

Run by New York State Psychiatric Institute · NCT05918835 · Data updated 2026-11-12

This study will try high-frequency rTMS to the DLPFC to see if it reduces restrictive food choices in adult women hospitalized with anorexia nervosa.

More Anorexia Nervosa trials

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexWomen only
Enrollment72 (estimated)
SponsorNew York State Psychiatric Institute
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedApril 24, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJuly 15, 2026
Trial IDNCT05918835 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are right-handed female adults aged 18–30 with DSM-5 anorexia nervosa, BMI ≥16, medically stable and voluntarily admitted to the NYSPI inpatient eating disorders unit.

Probably not a fit

Patients with a history of seizures, implanted ferromagnetic devices, active substance use disorder or psychosis, significant medical or neurological illness, or food restrictions that affect the task are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll right-handed women ages 18–30 with DSM-5 anorexia nervosa who are voluntarily admitted to the NYSPI inpatient unit. Participants are randomized in a double-blind, parallel design to receive neuronavigation-guided high-frequency rTMS to an individualized DLPFC target or a sham procedure. fMRI and a computerized food-choice task are performed before and after intervention to measure changes in dorsal striatum activity and restrictive food choice behavior. Group comparisons will test whether modulating DLPFC activity alters the neural circuits thought to drive restrictive eating.

Why it matters

Potential benefit: If successful, this approach could reduce restrictive food choices and help patients broaden their diets, potentially lowering relapse risk.

How similar studies have gone: Prior small rTMS studies targeting prefrontal regions in anorexia and related disorders have shown mixed but encouraging preliminary results, so the approach is promising but still experimental.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* DSM-5 Diagnosis of Anorexia Nervosa
* Age 18-35 years
* Female
* Right-handed
* Body Mass Index (BMI) ≥ 16.0
* Voluntarily admitted to inpatient eating disorders unit at NYSPI
* Competent to provide informed consent
* English-speaking
* Medically stable

Exclusion Criteria:

* High risk of suicide
* Current substance use disorder or other co- morbid psychiatric condition requiring specialized treatment (e.g., psychosis)
* Diagnosis of major medical or neurological problem or taking medication that significantly increases risk for seizure or affects interpretation of findings (e.g., unstable hypertension, seizure disorder)
* Food restrictions (e.g., allergies) which impact greater than 30% of food choice task's choice options
* Indwelling ferromagnetic metallic object (e.g., pacemaker, pump), non- removable metal jewelry, medicinal patch or recent metallic ink tattoo
* History of seizure
* Diagnosis of epilepsy, stroke, multiple sclerosis, traumatic brain injury, Alzheimer's and other neurodegenerative diseases, meningoencephalitis or intracerebral abscess, or parenchymal or leptomeningeal cancers
* Prior exposure to TMS
* Pregnancy
* Currently breast-feeding
* Significant claustrophobia
* Implanted devices or stimulators
* Hearing loss (e.g., currently undergoing treatment with ototoxic medications or those with cochlear implants)

Where it's running

  • New York State Psychiatric Institute
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Alexandra F Muratore, PhD — New York Sate Psychiatric Institute
  • Study coordinator: Alexandra F Muratore, PhD
  • Email: afm2166@cumc.columbia.edu
  • Phone: 646-774-8053

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.